About this event

  • Date and time Thu 19 May 2022 from 5:30pm to 7:45pm
  • Location Royal Society of Medicine
  • Organised by Ophthalmology

This meeting will inform delegates of the latest thinking in the management of intraocular inflammation. Expert speakers in this field will discuss the next five years of intraocular inflammation and explore what is likely to come into clinical practice during that time.

This evening event will cover state-of-the-art topics in intraocular inflammation. Each speaker has been asked to describe best practices in the diagnosis and management of ocular inflammatory diseases. In addition, they will predict which new drugs and technology are likely to come into clinical practice in the near future.

During this meeting delegates will:

  • Appreciate the current best practices for intraocular inflammation
  • Understand how the best practices will change in the near future
  • Learn about new drugs and technology upcoming for intraocular inflammation

20 x bursary places (x10 student and x10 trainee places) are available for this meeting. Please send your request to ophthalmology@rsm.ac.uk

Can’t attend in person on the day? This event is available to watch on-demand for up to 60 days. Please register for the pre-recorded webinar here. The link to watch the webinar will be sent via email three days after the live in-person event on Saturday 22 May 2022 so that you can view it on-demand.  

Join in the conversation online 
Follow us on Twitter: @RoySocMed

 

Key speakers

Professor Alastair Denniston

Consultant Ophthalmologist and Honorary Professor, University Hospitals Birmingham NHS Foundation Trust

Speaker's biography

Professor Alastair Denniston is a Consultant Ophthalmologist specialising in uveitis at University Hospitals Birmingham NHS Foundation Trust, one of the UK’s largest acute healthcare organisations. His work focuses on use of health data research and the application of digital healthcare (including artificial intelligence) to improve patient care in the ‘real world’. Professor Denniston leads a team committed to ensuring that the best innovation within the broad field of ‘artificial intelligence’ is translated safely, efficiently, equitably and inclusively to patients. This includes improving the design and reporting of clinical trials in this area (CONSORT-AI and SPIRIT-AI), highlighting issues of representativeness including the risk of health data poverty; developing tools to support safe deployment (including validation datasets); and working with regulators and other stake-holder groups to support the best of these innovations right through the implementation pathway to routine patient care and public health. Professor Denniston has a particular interest in the use of routinely collected data and digital innovation to tackle sight-threatening disease. He is the Director of INSIGHT, the UK’s Health Data Research Hub for Eye Health which is focused on eye disease and its application to wider health, including diabetes and dementia (unlocking the power of ‘oculomics’). INSIGHT enables the use of anonymised large-scale data and advanced analytics, including artificial intelligence, to develop new insights in disease detection, diagnosis, treatments and personalised healthcare. Professor Denniston is a Member of the UK Government’s Regulatory Horizons Council, AI Theme Lead for the Centre for Regulatory Science and Innovation (Birmingham, UK), and part of the UK’s Biomedical Research Centre for Ophthalmology (Moorfields Eye Hospital/UCL).

Professor Carlos Pavesio

Professor of Ocular Inflammation and Infection, University College London and Consultant Ophthalmic Surgeon, Moorfields Eye Hospital

Speaker's biography

Professor Carlos Pavesio is Professor of Ocular Inflammation and Infection at University College London in London and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London, UK. He was the Medical Retina Service Director between 2008 and 2016 and is currently Co-Director of the Uveitis Service at Moorfields. He is the Uveitis theme leader for the Biomedical Research Centre, Institute of Ophthalmology, London.  He is also Director of the Fellowship Programme at Moorfields Eye Hospital and Chairman of the Infection Control Committee. Professor Pavesio is a Member of many international ophthalmological societies, including IOIS (International Ocular Inflammation Society), IUSG (International Uveitis Study Group). He was a board member for the SOE and EUPO (European Union of Professors of Ophthalmology).  For over 10 years he has been the organiser of the Uveitis Programme for EURETINA and SOE, apart from having organised more than 10 International Uveitis Courses, both in the UK and abroad. He has given more than 300 lectures both in the UK and Internationally. He was visiting Professor of Ophthalmology in New Zealand in 2009 and HMDP Visiting Expert in Ophthalmology – Uveitis, Intraocular Inflammation, Medical Retina in Singapore in 2014. He has also been a faculty member for the Cole Eye Institute Uveitis Course held in Cleveland, USA. Professor Pavesio is the Editor-in-Chief for the Journal of Ophthalmic Inflammation and Infection and a member of the editorial board of the British Journal of Ophthalmology, Ocular Immunology and Inflammation, International Ophthalmology, and Journal of Ocular Infections and Inflammation and Ophthalmology. He has co-edited five books in Ophthalmology and has authored more than 30 book chapters. He has over 200 peer-reviewed publications in the field.

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Mr Miles Stanford, Consultant Ophthalmologist, St Thomas’ Hospital

The epidemiology of intraocular inflammation in the UK – the use of big data

Dr Tasanee Braithwaite, Consultant Ophthalmologist (Uveitis and Neuro-Ophthalmology), The Medical Eye Unit, Guy’s and St Thomas’ NHS Foundation Trust

New methods of imaging in diagnosis and management

Professor Alastair Denniston, Consultant Ophthalmologist and Honorary Professor, University Hospitals Birmingham NHS Foundation Trust

Paediatric uveitis; Current practice and future potential

Mr Harry Petrushkin, Consultant, Moorfields Eye Hospital

Advances in local therapies

Professor Carlos Pavesio, Professor of Ocular Inflammation and Infection, University College London and Consultant Ophthalmic Surgeon, Moorfields Eye Hospital

Developments in systemic therapies

Mr William Tucker, Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust

Panel discussion
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Can't make this event? Book the live stream here:

OPQ04 Promo
CPD

Live stream: Horizon scanning in intraocular inflammation

This meeting will inform delegates of the latest thinking in the management of intraocular inflammation. Expert speakers in this field will discuss the next five years of intraocular inflammation and explore what is likely to come into clinical practice during that time.

Disclaimer: All views expressed at this event are of the speakers themselves and not of the RSM nor the speaker's organisations.

Registration for this event will close at 01:0am on 18 May 2021Late registrations will not be accepted.

This event will be recorded and stored by the Royal Society of Medicine and may be  distributed  in future on various internet channels